 | |
|
Robert Bruce
13F | |
| Bruce & Co. | |
| Last update 2022-11-15 | 30 Stocks (1 new) |
| Value $342.00 Mil | Turnover 3 % |
| Portfolio Report | |
Robert Bruce Profile
Robert Bruce is the founder of Bruce & Co, the investment firm that serves as the advisor to the Bruce Fund (BRUFX). The Bruce Fund is run by Robert Bruce and his son, Robert Jeffrey Bruce. The Fund focuses primarily on common stock investments, though it also invests in high-yield and distressed debt. It may invest in some long-term U.S. government securities if the managers cannot find attractive opportunities elsewhere.
Robert Bruce Investing Philosophy
The Fund invests mostly in small- and mid-cap stocks, with the occasional large-cap, as well as convertible and distressed bonds. The Bruces tend to hold their stocks for the long-term, generally preferring the securities of distressed companies that are trading at a significant discount but which they believe can make a turnaround.
Robert Bruce's Portfolio
Robert Bruce Current Holdings
| Ticker |
|---|
| Ticker |
IIIN |
T |
UHAL |
ABBV |
MRK |
PFE |
ABT |
AVA |
EDAP |
PRTK |
NEM |
ASH |
AMYT |
FATE |
IGMS |
OGN |
MNKD |
VTRS |
RLI |
CMS |
| Ticker | | Company | Industry | Market Cap $Mil | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | | Company | Industry | Market Cap $Mil | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % |
IIIN | Insteel Industries Inc | Industrial Products | 585.87 | 274,000 | 7,269.00 | New Holding | 2.12 | +2.12% | 1.40 | +23.61% | +9.45% | |
T | AT&T Inc | Telecommunication Services | 136,572.48 | 1,072,000 | 16,444.00 | +16.27% | 4.81 | +0.67% | 0.02 | +4.67% | +5.58% | |
UHAL | Amerco Inc | Business Services | 13,480.35 | 754,550 | 38,423.00 | 0% | 11.23 | 0% | 0.04 | +29.98% | +14.22% | |
ABBV | AbbVie Inc | Drug Manufacturers | 255,739.97 | 223,500 | 29,995.00 | 0% | 8.77 | 0% | 0.01 | -1.64% | -9.60% | |
MRK | Merck & Co Inc | Drug Manufacturers | 270,374.63 | 323,700 | 27,877.00 | 0% | 8.15 | 0% | 0.01 | +5.78% | -3.88% | |
PFE | Pfizer Inc | Drug Manufacturers | 246,873.57 | 542,700 | 23,748.00 | 0% | 6.94 | 0% | 0.01 | -6.25% | -13.37% | |
ABT | Abbott Laboratories | Medical Devices & Instruments | 192,141.83 | 167,600 | 16,216.00 | 0% | 4.74 | 0% | 0.01 | +11.11% | +0.84% | |
AVA | Avista Corp | Utilities - Regulated | 2,995.30 | 205,000 | 7,595.00 | 0% | 2.22 | 0% | 0.28 | +12.19% | -8.43% | |
EDAP | Edap TMS SA | Medical Devices & Instruments | 398.37 | 565,652 | 4,666.00 | 0% | 1.36 | 0% | 1.56 | +6.78% | +3.38% | |
PRTK | Paratek Pharmaceuticals Inc | Biotechnology | 114.99 | 1,557,312 | 4,002.00 | 0% | 1.17 | 0% | 2.80 | -1.43% | +10.70% | |
NEM | Newmont Corp | Metals & Mining | 38,377.27 | 65,000 | 2,731.00 | 0% | 0.80 | 0% | 0.01 | +11.77% | +2.44% | |
ASH | Ashland Inc | Chemicals | 5,804.89 | 25,000 | 2,374.00 | 0% | 0.69 | 0% | 0.05 | -0.36% | -0.53% | |
AMYT | Amryt Pharma PLC | Drug Manufacturers | 933.22 | 315,182 | 2,181.00 | 0% | 0.64 | 0% | 0.49 | +109.14% | +100.55% | |
FATE | Fate Therapeutics Inc | Biotechnology | 627.72 | 57,000 | 1,277.00 | 0% | 0.37 | 0% | 0.06 | -67.06% | -35.98% | |
IGMS | IGM Biosciences Inc | Biotechnology | 955.03 | 55,000 | 1,250.00 | 0% | 0.37 | 0% | 0.13 | +29.65% | +31.10% | |
OGN | Organon & Co | Drug Manufacturers | 7,549.54 | 31,970 | 748.00 | 0% | 0.22 | 0% | 0.01 | +27.16% | +6.27% | |
MNKD | MannKind Corp | Biotechnology | 1,342.30 | 195,073 | 602.00 | 0% | 0.18 | 0% | 0.07 | +33.86% | -3.23% | |
VTRS | Viatris Inc | Drug Manufacturers | 14,455.20 | 61,512 | 524.00 | 0% | 0.15 | 0% | 0.01 | +8.47% | +7.10% | |
RLI | RLI Corp | Insurance | 6,070.24 | 2,400 | 245.00 | 0% | 0.07 | 0% | 0.01 | +7.48% | +1.70% | |
CMS | CMS Energy Corp | Utilities - Regulated | 17,673.42 | 418,500 | 24,373.00 | -6.69% | 7.12 | -0.50% | 0.14 | +6.97% | -3.85% |
Total 30